glp 1 ckd Healthcare utilization, mortality, and cardiovascular events following GLP1-RA initiation in chronic kidney disease GLP-1 receptor agonists and next-generation

Patients who escalate too quickly are the ones who tend to be miserable on these medications

Research shows substantial results for these drugs, especially GLP-1s

Many research studies cant collect data with the speed, volume, detail, and diversity that the likes of Clue provide.

The FDA's 2024 guidance on compounded semaglutide states: "Patients should be aware that FDA has not reviewed compounded versions of semaglutide for safety, effectiveness, or quality." [1] Any telehealth company, Mochi Health included, that prescribes compounded semaglutide carries that unverified-safety exposure

Applying it 3 times a week instead of daily reduces the cumulative follicle stimulation significantly